Oaktree Acquisition Corp. III Life Sciences (OACC) Stock Price, News & Analysis

Company Overview

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.

Key Stats

• Today's Range: $10.47 to $10.54
• 50-Day Range: $10.07 to $10.53
• 52-Week Range: $9.95 to $10.85
• Volume: 225 shs
• Average Volume: 116,754 shs
• Market Capitalization: $236.36 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OACC Stock Analysis - Frequently Asked Questions

How have OACC shares performed this year?

Oaktree Acquisition Corp. III Life Sciences' stock was trading at $10.01 at the start of the year. Since then, OACC stock has increased by 5.3% and is now trading at $10.54.
View the best growth stocks for 2025 here.

Who are Oaktree Acquisition Corp. III Life Sciences' major shareholders?

Oaktree Acquisition Corp. III Life Sciences' top institutional shareholders include AQR Arbitrage LLC (6.47%), Driehaus Capital Management LLC (4.01%), Linden Advisors LP (2.68%) and Goldman Sachs Group Inc. (2.36%).

How do I buy shares of Oaktree Acquisition Corp. III Life Sciences?

Shares of OACC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 6/10/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Financial Services
• Industry: Holding & other investment offices
• Sub-Industry: Trading
• Current Symbol: NASDAQ:OACC
• CIK: 2029769
• Web: N/A
• Phone: (213) 830-6300
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 22,425,000
• Free Float: N/A
• Market Cap: $235.91 million
• Optionable: N/A
• Beta: N/A